Menu

Image of the Day: Cellular Destiny

Progenitor cells in the pancreas of humans get developmental cues from proteins in their environment.

Dec 11, 2018
Carolyn Wilke
An embryonic pancreatic bud that was grown ex vivo from human cells
DANSTEM

R

esearchers have cracked the code that guides immature human pancreatic cells to their destiny. The results of this study, published in Nature on November 28, could help scientists direct stem cells to grow into the insulin-producing ones for potential use in replacement therapy for type 1 diabetes.

The researchers attached pancreatic progenitor cells, which are similar to stem cells but have a limited capacity to replicate, to a glass slide that was covered in different types of proteins. They could then watch how the cells reacted to the proteins without the interference of neighbor cells. They also observed mechanical force changes inside each cell that cued its development. Specifically, the protein laminin prodded progenitor cells into becoming endocrine cells, such as the insulin-producing beta cell, by reducing their mechanical force. 

These results provide the tools “to more precisely engineer cells that are lost or damaged in severe diseases, such as type 1 diabetes and neurodegenerative diseases, for future cell replacement therapies,” study author Henrick Semb says in a statement.

A. Mamidi, et al., “Mechanosignalling via integrins directs fate decisions of pancreatic progenitors,” Naturedoi:10.1038/s41586-018-0762-2, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.